Not logged in Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2,-3, and-7 trials Andre, F.; Solovieff, N.; Su, F.; Bardia, A.; Neven, P.; Yap, Y. S.; Tripathy, D.; Lu, Y. -S.; Slamon, D.; Chia, S.; Joshi, M.; Chakravartty, A.; Lteif, A.; Taran, T.; Arteaga, C. L. Share Save
Methodology for Good Machine Learning with Multi-Omics Data Coroller, Thibaud; Sahiner, Berkman; Amatya, Anup; Gossmann, Alexej; Karagiannis, Konstantinos; Moloney, Conor; Samala, Ravi K.; Santana-Quintero, Luis; Solovieff, Nadia; Wang, Craig; Amiri-Kordestani, Laleh; Cao, Qian; Cha, Kenny H.; Charlab, Rosane; Cross, Frank H.; Hu, Tingting; Huang, Ruihao; Kraft, Jeffrey; Krusche, Peter; Li, Yutong; Li, Zheng; Mazo, Ilya; Paul, Rahul; Schnakenberg, Susan; Serra, Paolo; Smith, Sean; Song, Chi; Su, Fei; Tiwari, Mohit; Vechery, Colin; Xiong, Xin; Zarate, Juan Pablo; Zhu, Hao; Chakravartty, Arunava; Liu, Qi; Ohlssen, David; Petrick, Nicholas; Schneider, Julie A.; Walderhaug, Mark; Zuber, Emmanuel Share Save
Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials Andre, F.; Su, F.; Solovieff, N.; Hortobagyi, G.; Chia, S.; Neven, P.; Bardia, A.; Tripathy, D.; Lu, Y. -s.; Lteif, A.; Taran, T.; Babbar, N.; Slamon, D.; Arteaga, C. L. Share Save
Clonal hematopoiesis detection in patients with cancer using cell-free DNA sequencing Fairchild, Lauren; Whalen, Jeanne; D 'Aco, Katie; Wu, Jincheng; Gustafson, Carroll B.; Solovieff, Nadia; Su, Fei; Leary, Rebecca J.; Campbell, Catarina D.; Balbin, O. Alejandro Share Save
Identification of mechanisms of acquired resistance to ribociclib plus endocrine therapy using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2,-3, and-7 trials Andre, Fabrice; Solovieff, Nadia; Su, Faye; Bardia, Aditya; Neven, Patrick; Yap, Yoon-Sim; Tripathy, Debu; Lu, Yen-Shen; Slamon, Dennis; Chia, Stephen K.; Joshi, Mukta; Chakravartty, Arunava; Lteif, Agnes; Taran, Tetiana; Arteaga, Carlos Share Save
Pooled gene expression analysis and association with treatment response in patients with HR+/HER2-advanced breast cancer in the MONALEESA-2,-3, and-7 trials Bardia, Aditya; Su, Faye; Solovieff, Nadia; Andre, Fabrice; Arteaga, Carlos; Neven, Patrick; Yap, Yoon-Sim; Lu, Yen-Shen; Chia, Stephen K.; Slamon, Dennis; Im, Seock-Ah; Chakravartty, Arunava; Lteif, Agnes; Taran, Tetiana; Tripathy, Debu Share Save
Upregulation of immune response biomarkers by ribociclib plus endocrine therapy (ET) in paired tumor samples from phase I studies Juric, Dejan; Ma, Chong; Tiedt, Ralph; Yap, Yoon-Sim; Chiu, Joanne; Munster, Pamela; Ismail-Khan, Roohi; Garcia-Estevez, Laura; Mayer, Ingrid A.; Becerra, Carlos; Solovieff, Nadia; Lteif, Agnes; Su, Faye; Lu, Yen-Shen Share Save
Correlative analysis of overall survival by intrinsic subtype across the MONALEESA-2,-3, and-7 studies of ribociclib plus endocrine therapy in patients with HR+/HER2-advanced breast cancer Carey, Lisa; Solovieff, Nadia; Andre, Fabrice; O'Shaughnessy, Joyce; Cameron, David A.; Janni, Wolfgang; Sonke, Gabe S.; Yap, Yoon-Sim; Yardley, Denise A.; Zarate, Juan Pablo; Taran, Tetiana; Su, Faye; Lteif, Agnes; Prat, Aleix Share Save
Genomic profiling of PAM50-based intrinsic subtypes in HR+/HER2-advanced breast cancer (ABC) across the MONALEESA (ML) studies Prat, Aleix; Solovieff, Nadia; Su, Faye; Bardia, Aditya; Neven, Patrick; Hortobagyi, Gabriel N.; Tripathy, Debu; Chia, Stephen; Slamon, Dennis; Lu, Yen-Shen; Taran, Tetiana; Lteif, Agnes; Arteaga, Carlos L.; Andre, Fabrice Share Save
PLATForM: Descriptive analysis from a randomised, phase II study of novel spartalizumab combinations in previously treated unresectable/metastatic melanoma Robert, C.; Schadendorf, D.; Long, G. V.; Ascierto, P.; Intagliata, S.; Meier, F.; van der Veldt, A. A. M.; Ribas, A.; Weber, J. S.; Stenson, L.; Solovieff, N.; Louveau, A-L.; Boran, A. D.; Grob, J. J.; Dummer, R. Share Save
Share Save
Baseline circulating tumor DNA (ctDNA) analysis in Asian women with HR+/HER2-advanced breast cancer (ABC) receiving ribociclib plus endocrine therapy in the Phase Ib MONALEESASIA trial Yap, Yoon-Sim; Su, Faye; Solovieff, Nadia; Ito, Yoshinori; Masuda, Norikaza; Ishikawa, Takashi; Aruga, Tomoyuki; Kim, Seung Jin; He, Wei; Gazdoiu, Mihaela; Chiu, Joanne Share Save
Genetic landscape of premenopausal HR+/HER2-advanced breast cancer (ABC) based on comprehensive circulating tumor DNA analysis and association with clinical outcomes in the Phase III MONALEESA-7 trial Bardia, Aditya; Su, Faye; Solovieff, Nadia; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Villanueva Vazquez, Rafael; Lu, Yen-Shen; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Lorenc, Karen Rodriguez; Taran, Tetiana; Babbar, Naveen; Tripathy, Debu Share Save
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER plus breast cancer Formisano, Luigi; Lu, Yao; Servetto, Alberto; Hanker, Ariella B.; Jansen, Valerie M.; Bauer, Joshua A.; Sudhan, Dhivya R.; Guerrero-Zotano, Angel L.; Croessmann, Sarah; Guo, Yan; Ericsson, Paula Gonzalez; Lee, Kyung-Min; Nixon, Mellissa J.; Schwarz, Luis J.; Sanders, Melinda E.; Dugger, Teresa C.; Cruz, Marcelo Rocha; Behdad, Amir; Cristofanilli, Massimo; Bardia, Aditya; O'Shaughnessy, Joyce; Nagy, Rebecca J.; Lanman, Richard B.; Solovieff, Nadia; He, Wei; Miller, Michelle; Su, Fei; Shyr, Yu; Mayer, Ingrid A.; Balko, Justin M.; Arteaga, Carlos L. Share Save
Biomarker analysis by baseline circulating tumor DNA alterations in the MONALEESA-3 study Neven, P.; Petrakova, K.; Bianchi, G. Val; De la Cruz-Merino, L.; Jerusalem, G.; Sonke, G. S.; Nusch, A.; Beck, J. T.; Chia, S.; Solovieff, N.; Lorenc, K. Rodriguez; Miller, M.; Su, F.; Lm, S-A Share Save
Biomarker analysis in HR+, HER2-, locally advanced, or metastatic breast cancer patients treated with buparlisib: results from BELLE-3 Solovieff, Nadia; Wang, Ying A.; Sankaran, Banu; Scheuer, Nicolas; El-Hashimy, Mona; Weber, Denis; Sellami, Dalila; Di Leo, Angelo Share Save
Biomarker results from BERIL-1: buparlisib and paclitaxel in patients with platinum-pretreated SCCHN Soulieres, D.; Faivre, S.; Mesia, R.; Remenar, E.; Li, S. H.; Karpenko, A.; Dechaphunkul, A.; Keilholz, U.; Kiss, L.; Lin, J. C.; Nagarkar, R.; Tamas, L.; Kim, S. B.; Erfan, J.; Alyasova, A.; Yovine, A.; Le Mouhaer, S.; Solovieff, N.; Turri, S.; Licitra, L. Share Save
Ribociclib plus letrozole in early breast cancer: A presurgical, window-of-opportunity study Curigliano, G.; Gomez Pardo, P.; Meric-Bernstam, F.; Conte, P.; Lolkema, M. P.; Beck, J. T.; Bardia, A.; Martinez Garcia, M.; Penault-Llorca, F.; Dhuria, S.; Tang, Z.; Solovieff, N.; Miller, M.; Di Tomaso, E.; Hurvitz, S. A. Share Save
Biomarkers of drug response to buparlisib: Results of next-generation sequencing in a phase II trial of advanced endometrial carcinoma Solovieff, Nadia; Singh, Angad Pal; Bitter, Hans; Riester, Markus; Teneriello, Michael; Oza, Amit; Monk, Bradley; Robinson, Douglas; Trandafir, Lucia; Massacesi, Cristian; di Tomaso, Emmanuelle; Naumann, R. Wendel Share Save
No association between RORA polymorphisms and PTSD in two independent samples Guffanti, G.; Ashley-Koch, A. E.; Roberts, A. L.; Garrett, M. E.; Solovieff, N.; Ratanatharathorn, A.; De Vivo, I.; Dennis, M.; Ranu, H.; Smoller, J. W.; Liu, Y.; Purcell, S. M.; Beckham, J.; Hauser, M. A.; Koenen, K. C. Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
